Variant report
Variant | esv1814444 |
---|---|
Chromosome Location | chr16:12018945-12036540 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:47)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:7)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:47 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOSL2 | chr16:12029595-12029917 | HepG2 | liver: | n/a | n/a |
2 | FOSL2 | chr16:12019327-12019857 | HepG2 | liver: | n/a | n/a |
3 | FOSL2 | chr16:12024280-12024663 | HepG2 | liver: | n/a | n/a |
4 | FOSL2 | chr16:12022724-12022963 | HepG2 | liver: | n/a | n/a |
5 | GABPA | chr16:12019566-12019702 | GM12878 | blood: | n/a | n/a |
6 | GATA1 | chr16:12021199-12021610 | PBDE | blood: | n/a | n/a |
7 | GATA2 | chr16:12030265-12030454 | K562 | blood: | n/a | n/a |
8 | JUND | chr16:12019557-12019676 | HepG2 | liver: | n/a | n/a |
9 | JUND | chr16:12019512-12019704 | HepG2 | liver: | n/a | n/a |
10 | JUND | chr16:12024272-12024458 | HepG2 | liver: | n/a | n/a |
11 | PAX5 | chr16:12021158-12021555 | GM12878 | blood: | n/a | n/a |
12 | PAX5 | chr16:12021286-12021482 | GM12878 | blood: | n/a | n/a |
13 | PAX5 | chr16:12021214-12021525 | GM12878 | blood: | n/a | n/a |
14 | PAX5 | chr16:12023413-12023561 | GM12878 | blood: | n/a | n/a |
15 | PAX5 | chr16:12021188-12021528 | GM12878 | blood: | n/a | n/a |
16 | PAX5 | chr16:12029566-12029934 | GM12878 | blood: | n/a | chr16:12029707-12029724 |
17 | PAX5 | chr16:12029572-12029898 | GM12878 | blood: | n/a | chr16:12029707-12029724 |
18 | POLR2A | chr16:12029530-12029941 | GM12878 | blood: | n/a | n/a |
19 | POLR2A | chr16:12029541-12029924 | GM12892 | blood: | n/a | n/a |
20 | POLR2A | chr16:12035076-12035657 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | POLR2A | chr16:12029542-12029927 | GM12891 | blood: | n/a | n/a |
22 | POLR2A | chr16:12018910-12019275 | PANC-1 | pancreas: | n/a | n/a |
23 | POLR2A | chr16:12035427-12035589 | GM12878 | blood: | n/a | n/a |
24 | POLR2A | chr16:12035289-12035661 | GM12892 | blood: | n/a | n/a |
25 | POLR2A | chr16:12022704-12022980 | GM12878 | blood: | n/a | n/a |
26 | POLR2A | chr16:12035411-12035565 | Hela-S3 | cervix: | n/a | n/a |
27 | POLR2A | chr16:12035380-12035582 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | POLR2A | chr16:12024255-12024692 | GM12878 | blood: | n/a | n/a |
29 | POLR2A | chr16:12035371-12035564 | H1-hESC | embryonic stem cell: | n/a | n/a |
30 | POLR2A | chr16:12035297-12035682 | GM12878 | blood: | n/a | n/a |
31 | POLR2A | chr16:12035426-12035555 | GM12878 | blood: | n/a | n/a |
32 | POLR2A | chr16:12024268-12024481 | Hela-S3 | cervix: | n/a | n/a |
33 | POLR2A | chr16:12021376-12021488 | GM12878 | blood: | n/a | n/a |
34 | POLR2A | chr16:12029596-12029997 | GM12891 | blood: | n/a | n/a |
35 | POU2F2 | chr16:12024262-12024549 | GM12878 | blood: | n/a | n/a |
36 | RCOR1 | chr16:12021395-12021483 | K562 | blood: | n/a | n/a |
37 | SIN3AK20 | chr16:12025300-12025389 | HepG2 | liver: | n/a | n/a |
38 | TAF1 | chr16:12035299-12035584 | H1-hESC | embryonic stem cell: | n/a | n/a |
39 | TBP | chr16:12035454-12035609 | H1-hESC | embryonic stem cell: | n/a | n/a |
40 | TCF12 | chr16:12019509-12019717 | HepG2 | liver: | n/a | n/a |
41 | TCF12 | chr16:12021346-12021503 | GM12878 | blood: | n/a | n/a |
42 | UBTF | chr16:12021213-12021613 | K562 | blood: | n/a | n/a |
43 | UBTF | chr16:12021319-12021596 | K562 | blood: | n/a | n/a |
44 | USF1 | chr16:12024306-12024453 | HepG2 | liver: | n/a | n/a |
45 | USF1 | chr16:12024335-12024451 | HepG2 | liver: | n/a | n/a |
46 | ZBTB33 | chr16:12024259-12024447 | HepG2 | liver: | n/a | n/a |
47 | ZNF384 | chr16:12021216-12021416 | K562 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:12010494..12013016-chr16:12016316..12019639,3 | MCF-7 | breast: |
(count:7 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-GSPT1-1 | chr16:12021452-12021736 | NONHSAT140608 |
2 | lnc-GSPT1-1 | chr16:12023242-12023494 | NONHSAT140609 |
3 | lnc-RP11-166B2.1.1-2 | chr16:12027682-12027781 | NONHSAT140610 |
4 | lnc-RP11-166B2.1.1-2 | chr16:12027480-12027518 | NONHSAT140610 |
5 | lnc-RP11-166B2.1.1-2 | chr16:12031397-12031525 | NONHSAT140610 |
6 | lnc-GSPT1-1 | chr16:12023097-12023200 | NONHSAT140608 |
7 | lnc-GSPT1-1 | chr16:12022838-12023132 | NONHSAT140609 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000234719 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs112824802 | chr16:12021275-12021276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs60168629 | chr16:12021284-12021285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs118142732 | chr16:12021288-12021289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs57225110 | chr16:12021292-12021293 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs60347225 | chr16:12021297-12021298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551208131 | chr16:12021298-12021299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141584024 | chr16:12021310-12021311 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530406082 | chr16:12021319-12021320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs79845530 | chr16:12021329-12021330 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs113445369 | chr16:12021331-12021332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs256390 | chr16:12021332-12021333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs565838037 | chr16:12021337-12021338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375815092 | chr16:12021341-12021342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116375279 | chr16:12021346-12021347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs112574008 | chr16:12021352-12021353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs552215023 | chr16:12021383-12021384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs71136701 | chr16:12021387-12021388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs568619596 | chr16:12021393-12021394 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537602553 | chr16:12021395-12021396 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554339465 | chr16:12021398-12021399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs200146217 | chr16:12021457-12021458 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs533821159 | chr16:12021458-12021459 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs553810246 | chr16:12021465-12021466 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs370684740 | chr16:12021477-12021478 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs145980981 | chr16:12021486-12021487 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs565342101 | chr16:12021497-12021498 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs577661186 | chr16:12021499-12021500 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs575813864 | chr16:12021502-12021503 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs544766302 | chr16:12021520-12021521 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs561449324 | chr16:12021565-12021566 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs201932636 | chr16:12021568-12021569 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs530343762 | chr16:12021585-12021586 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs544179686 | chr16:12021586-12021587 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs560635478 | chr16:12021609-12021610 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs532091746 | chr16:12021726-12021727 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs371701036 | chr16:12022852-12022853 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs374882977 | chr16:12022884-12022885 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs547916323 | chr16:12022933-12022934 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs256387 | chr16:12022979-12022980 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs200430589 | chr16:12023273-12023274 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs567892686 | chr16:12023440-12023441 | Inactive region | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs371870152 | chr16:12023441-12023442 | Inactive region | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs62040797 | chr16:12023505-12023506 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs533770925 | chr16:12023519-12023520 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs78395476 | chr16:12023542-12023543 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs687500 | chr16:12023543-12023544 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs80094987 | chr16:12023553-12023554 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs199906866 | chr16:12024345-12024346 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs201218967 | chr16:12024360-12024361 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs575740545 | chr16:12024389-12024390 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 21183584 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 17603634 | CNVD |
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21858162 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22102821 | CNVD |
Autism | 22495311 | CNVD |
idiopathic generalized epilepsy | 19843651 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Intellectual disability | 22102821 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Prostate cancer | 18632612 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Lujan-Fryns syndrom | 21521776 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 19786961 | CNVD |
Mental retardation | 19786961 | CNVD |
Schizophrenia | 19786961 | CNVD |
Mental retardation | 19951919 | CNVD |
Autism | 18791038 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Autism | 17480035 | CNVD |
Schizophrenia | 19955444 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Melanoma | 20877625 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:12021200-12021400 | Enhancers | K562 | blood |
2 | chr16:12030000-12030200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr16:12030800-12031000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr16:12030800-12031600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr16:12035400-12035800 | Enhancers | H1 Cell Line | embryonic stem cell |